Literature DB >> 6394353

The collagens of the developing bovine cornea.

R E Lee, P F Davison.   

Abstract

The morphology of the developing bovine eye has been examined and the collagens in fetal bovine eyes from three months' gestation to maturity have been solubilized by pepsin treatment and analyzed to determine the ratios of the predominant types of collagen. The type I collagen decreased, while the type V collagen increased with age. Type III collagen comprised less than 1% of all the corneas, except for the three-month fetal calf. The anterior to posterior thickness of the paraffin-embedded fetal calf cornea increased from the third to the seventh month, decreased from the seventh month to birth, and then increased after birth. Descemet's membrane increased in thickness with age. Analysis of dissected regions of the calf cornea showed a uniform distribution of the collagen populations from the center to the limbus (89% type I, 10% type V and less than 1% type III collagen) and uniformity through the depth of the stroma, except that type III was concentrated around Bowman's layer, and type IV in Descement's membrane. The localization of the different collagens was consistent with the immunofluorescent staining studies with anticollagen antibodies, but the ratios of the intensities of the fluorescence did not correspond to the quantitative analyses. These results are concordant with other studies that have shown that antibody binding may be masked or diminished in certain tissues and therefore immunofluorescence cannot be used reliably for quantitative measurements.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394353     DOI: 10.1016/0014-4835(84)90063-0

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

1.  Immunogold fine structural localization of extracellular matrix components in aged human cornea. II. Collagen types V and VI.

Authors:  G E Marshall; A G Konstas; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Immunogold fine structural localization of extracellular matrix components in aged human cornea. I. Types I-IV collagen and laminin.

Authors:  G E Marshall; A G Konstas; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Immunocytochemical localisation of collagens (I-V) in the human iris.

Authors:  A G Konstas; G E Marshall; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Production of neocollagen by cells invading hydrogel sponges implanted in the rabbit cornea.

Authors:  T V Chirila; D E Thompson-Wallis; G J Crawford; I J Constable; S Vijayasekaran
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

Review 5.  Importance of the stem cell microenvironment for ophthalmological cell-based therapy.

Authors:  Peng-Xia Wan; Bo-Wen Wang; Zhi-Chong Wang
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

6.  Collagen arrangements in ureter.

Authors:  P Dorrell; R Wilkinson; S D Gorham; M Aitchison; R Scott
Journal:  Urol Res       Date:  1993

Review 7.  Corneal Regeneration After Photorefractive Keratectomy: A Review.

Authors:  Javier Tomás-Juan; Ane Murueta-Goyena Larrañaga; Ludger Hanneken
Journal:  J Optom       Date:  2014-10-23

8.  Effect of Surgical Technique on Corneal Implant Performance.

Authors:  Monika Kozak Ljunggren; Rodolfo A Elizondo; Elle Edin; David Olsen; Kimberley Merrett; Chyan-Jang Lee; Göran Salerud; James Polarek; Per Fagerholm; May Griffith
Journal:  Transl Vis Sci Technol       Date:  2014-04-15       Impact factor: 3.283

9.  Collagen type I and type V are present in the same fibril in the avian corneal stroma.

Authors:  D E Birk; J M Fitch; J P Babiarz; T F Linsenmayer
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

Review 10.  Review: corneal epithelial stem cells, their niche and wound healing.

Authors:  Federico Castro-Muñozledo
Journal:  Mol Vis       Date:  2013-07-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.